Skip to main content
Erschienen in: European Journal of Epidemiology 4/2013

01.04.2013 | Letter to the Editor

Gout and the risk of Parkinson’s disease in Denmark

verfasst von: Eva Schernhammer, Jiaheng Qiu, Lene Wermuth, Christina Funch Lassen, Soren Friis, Beate Ritz

Erschienen in: European Journal of Epidemiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Excerpt

There is growing evidence that oxidative stress plays a major role in Parkinson’s disease (PD) etiology [1, 2]. Importantly, uric acid has been shown in experimental studies to have an antioxidant effect on neurons [3, 4]. Recently, several observational studies have also evaluated associations between serum uric acid levels and PD risk and have consistently reported a lower risk of PD among individuals with the highest levels of serum uric acid [510]. The most common metabolic disorder underlying hyper uricemia is gout. Thus, if hyperuricemia decreases the risk of PD, gout should also be negatively associated with PD risk. Two studies, to date, have evaluated the association between gout and PD risk and both reported an inverse association [11, 12], although the association was only observed among men in one of the two studies [11]. …
Literatur
1.
Zurück zum Zitat Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345(1–2):91–104.PubMedCrossRef Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345(1–2):91–104.PubMedCrossRef
2.
Zurück zum Zitat Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol 2013. doi:10.1007/s10654-012-9760-0. Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol 2013. doi:10.​1007/​s10654-012-9760-0.
3.
Zurück zum Zitat Church WH, Ward VL. Uric acid is reduced in the substantia nigra in Parkinson’s disease: effect on dopamine oxidation. Brain Res Bull. 1994;33(4):419–25.PubMedCrossRef Church WH, Ward VL. Uric acid is reduced in the substantia nigra in Parkinson’s disease: effect on dopamine oxidation. Brain Res Bull. 1994;33(4):419–25.PubMedCrossRef
4.
Zurück zum Zitat Tohgi H, Abe T, Takahashi S, Kikuchi T. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1993;6(2):119–26.PubMedCrossRef Tohgi H, Abe T, Takahashi S, Kikuchi T. The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1993;6(2):119–26.PubMedCrossRef
5.
Zurück zum Zitat Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations on serum uric acid levels and the risk of idiopathic Parkinson’s disease. Am J Epidemiol. 1996;144(5):480–4.PubMedCrossRef Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM. Observations on serum uric acid levels and the risk of idiopathic Parkinson’s disease. Am J Epidemiol. 1996;144(5):480–4.PubMedCrossRef
6.
Zurück zum Zitat de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58(5):797–800.PubMedCrossRef de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58(5):797–800.PubMedCrossRef
7.
Zurück zum Zitat Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson’s disease. Am J Epidemiol. 2007;166(5):561–7.PubMedCrossRef Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson’s disease. Am J Epidemiol. 2007;166(5):561–7.PubMedCrossRef
8.
Zurück zum Zitat Larumbe Ilundain R, Ferrer Valls JV, Vines Rueda JJ, Guerrero D, Fraile P. Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson’s disease. Rev Esp Salud Publica. 2001;75(1):43–53.PubMedCrossRef Larumbe Ilundain R, Ferrer Valls JV, Vines Rueda JJ, Guerrero D, Fraile P. Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson’s disease. Rev Esp Salud Publica. 2001;75(1):43–53.PubMedCrossRef
9.
Zurück zum Zitat Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson’s disease. Mov Disord. 2007;22(8):1133–7.PubMedCrossRef Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson’s disease. Mov Disord. 2007;22(8):1133–7.PubMedCrossRef
10.
Zurück zum Zitat Cipriani S, Chen X, Schwarzschild MA. Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis. Biomark Med. 2010;4(5):701–12.PubMedCrossRef Cipriani S, Chen X, Schwarzschild MA. Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis. Biomark Med. 2010;4(5):701–12.PubMedCrossRef
11.
Zurück zum Zitat Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007;69(17):1696–700.PubMedCrossRef Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology. 2007;69(17):1696–700.PubMedCrossRef
12.
Zurück zum Zitat De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson’s disease: a cohort study. Arthritis Rheum. 2008;59(11):1549–54.PubMedCrossRef De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. Gout and the risk of Parkinson’s disease: a cohort study. Arthritis Rheum. 2008;59(11):1549–54.PubMedCrossRef
13.
Zurück zum Zitat Lynge E, Sandegaard JL, Rebolj M. The danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–3.PubMedCrossRef Lynge E, Sandegaard JL, Rebolj M. The danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–3.PubMedCrossRef
14.
Zurück zum Zitat Pedersen CB. The danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–5.PubMedCrossRef Pedersen CB. The danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–5.PubMedCrossRef
15.
Zurück zum Zitat Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 2011;34(5):1102–8.PubMedCrossRef Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B. Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 2011;34(5):1102–8.PubMedCrossRef
Metadaten
Titel
Gout and the risk of Parkinson’s disease in Denmark
verfasst von
Eva Schernhammer
Jiaheng Qiu
Lene Wermuth
Christina Funch Lassen
Soren Friis
Beate Ritz
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 4/2013
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-013-9791-1

Weitere Artikel der Ausgabe 4/2013

European Journal of Epidemiology 4/2013 Zur Ausgabe